Cover Image

PAPERBACK
$43.50



View/Hide Left Panel

Rodriguez, W.J., H.W.Kim, C.D.Brandt, B.Bise, A.Z.Kapikian, R.M. Chanock, G.Curlin, and R.H.Parrott. 1980. Rotavirus gastroenteritis in the Washington, D.C., area. Am. J. Dis. Child. 134(8):777–779.


Sack, D.A., A.M.A.K.Chowdhury, A.Eusof, M.A.Ali, M.H.Merson, S. Islam, R.E.Black, and K.H.Brown. 1978. Oral hydration in rotavirus diarrhoea: A double blind comparison of sucrose with glucose electrolyte solution. Lancet II:280–283.

Sato, K., Y.Inaba, T.Shinozaki, R.Fujii, and M.Matumoto. 1981. Isolation of human rotavirus in cell cultures: Brief report. Arch. Virol. 69(2):155–160.

Soenarto, Y., T.Sabodo, R.Ridho, H.Alrasjid, J.E.Rohde, H.C.Bugg, G.L.Barnes, and R.F.Bishop. 1981. Acute diarrhea and rotavirus infection in newborn babies and children in Yogyakarta, Indonesia, from June 1978–June 1979. J. Clin. Microbiol. 14:123–129.


Urasawa, T., S.Urasawa, and K.Taniguchi. 1981. Sequential passages of human rotavirus in MA-104 cells. Microbiol. Immunol. 25(10):1025–1035.


Vesikari, T., E.Isolauri, A.Delem, E.O’Hondt, F.E.André, and G.Zissis. 1983. Immunogenicity and safety of live attenuated bovine rotavirus vaccine strain RIT 4237 in adults and young children. Lancet II:807–811.

Vesikari, T., E.Isolauri, E.O’Hondt, A.Delem, F.E.André, and G. Zissis. 1984. Protection of infants against rotavirus diarrhoea by RIT 4237 attenuated bovine rotavirus strain vaccine. Lancet I:977–981.

Vesikari, T., E.Isolauri, F.E.André, E.d’Hondt, A.Delem, G.Zissis, G.Beards, and T.H.Flewett. 1985. Protection of infants against the human rotavirus diarrhea by the RIT 4237 live attenuated bovine rotavirus vaccine. Pp. 369–372 in Vaccines 85. Molecular and Chemical Basis of Resistance to Parasitic, Bacterial, and Viral Diseases, R.A.Lerner, R.M.Chanock, and F.Brown, eds. Cold Spring Harbor, N.Y.: Cold Spring Habor Laboratories.


Wyatt, R.G., C.A.Mebus, R.H.Yolken, A.R.Kalica, H.D.James, A.Z. Kapikian, and R.M.Chanock. 1979. Rotaviral immunity in gnotobiotic calves: Heterologous resistance to human virus induced by bovine virus. Science 203 (4380):548–550.

Wyatt, R.G., K.W.Thiel. L.J.Saif, A.R.Kalica, H.B.Greenberg, A.Z. Kapikian, and R.M.Chanock. 1980. Human rotavirus type 2: Cultivation in vitro. Science 207(4427):189–191.

Wyatt, R.G., H.B.Greenberg, W.D.James, A.L.Pittman, A.R.Kalica, J. Flores, R.M.Chanock, and A.Z.Kapikian. 1982. Definition of human rotavirus serotypes by plaque reduction assay. Infect. Immun. 37 (1):110–115.


Zissis, G., J.P.Lambert, P.Marbehant, D.Marissens, M.Lobmann, P. Charlier, A.Delem, and N.Zygraich. 1983. Protection studies in colostrum-deprived piglets of a bovine rotavirus vaccine candidate using human rotavirus strains for challenge. J. Infect. Dis. 148(6):1061–1068.



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement